Laxatives and cathartics

20,382views

Laxatives and cathartics

Internal Medicine

Internal Medicine

Blood transfusion reactions and transplant rejection: Pathology review
Immunodeficiencies: Clinical
Antihistamines for allergies
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Advanced cardiac life support (ACLS): Clinical
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Cardiomyopathies: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
MEN syndromes: Clinical
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Esophageal disorders: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Gastroparesis: Clinical
Malabsorption: Clinical
Inflammatory bowel disease: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Fever of unknown origin: Clinical
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Anemia: Clinical
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombophilia: Clinical
Myeloproliferative neoplasms: Clinical
Plasma cell disorders: Clinical
Blood products and transfusion: Clinical
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Infective endocarditis: Clinical
Pneumonia: Clinical
Tuberculosis: Pathology review
Diarrhea: Clinical
Viral hepatitis: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Bites and stings: Clinical
HIV and AIDS: Pathology review
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Environmental and chemical toxicities: Pathology review
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
Stroke: Clinical
Seizures: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Hyperkinetic movement disorders: Clinical
Hypokinetic movement disorders: Clinical
Muscle weakness: Clinical
Disorders of consciousness: Clinical
Spinal cord disorders: Pathology review
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
Anti-parkinson medications
Medications for neurodegenerative diseases
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Diffuse parenchymal lung disease: Clinical
Venous thromboembolism: Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Lung cancer: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Seronegative arthritis: Clinical
Systemic lupus erythematosus (SLE): Clinical
Sjogren syndrome: Clinical
Inflammatory myopathies: Clinical
Vasculitis: Clinical
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Non-biologic disease modifying anti-rheumatic drugs (DMARDs)
Osteoporosis medications

Transcript

Watch video only

Laxatives and cathartics are medications that increase the passage of stool.

Laxatives ease the passage of fully formed fecal matter from the rectum; while cathartics have a stronger effect, and cause the evacuation of the entire colon, usually in the form of watery, unformed stool.

Some medications can function both as a laxative and a cathartic, depending on the dosage.

Both types of medications are used to treat constipation, which is partly characterized by a decrease in stool passage frequency; small, hard stools; or difficulty with initiating bowel movements.

Normal stool frequency is usually at least 3 times per week for someone on a typical Western diet.

Now, the small and large intestines are where most of the absorption happens in the GI tract.

The small intestine contains smooth muscles that perform peristalsis, which is a series of coordinated wave-like muscle contractions that help push the food bolus through the GI tract.

Lining the luminal surface of the intestine is a layer called the mucosa, which absorbs nutrients or secretes different molecules, like ions and water, into the lumen.

The undigested component of the food bolus eventually reaches the large intestine and becomes feces or stool.

The large intestine mainly absorbs excess water from the stool and that helps condense it into a more solid form.

However, stool should still be 70-80% water by weight, so if the feces becomes too dry, it could condense into a large, hard mass that’s difficult to pass.

So instead of peristalsis, which only pushes the food bolus in one direction, the colon undergoes segmental contraction, which pushes the feces in both directions within the haustra to constantly mix it with water; kind of like how a cement truck keeps churning to keep the cement from drying.

Now, constipation can occur due to a poor diet or a malfunction within the GI tract itself, although, up to 60 percent of chronic constipation does not have a clear cause.

One of the most important dietary factors is the lack of fiber, which is the part of food that resists digestion and reaches the colon relatively unchanged.

Fiber usually comes from plants like fruits and vegetables.

They get incorporated into the stool where they absorb water, causing the stool to swell and bulk up, which prevents it from hardening, while also making it easier to pass.

Another cause of constipation is due to decreased motility of the GI tract, which could be caused by disorders like irritable bowel syndrome, or medications like opioids.

In either case, it takes longer for the digested food to travel through the GI tract, so more water is absorbed, and the stool hardens.

When this hardened stool forms a large mass that’s difficult to pass, it’s called a fecal impaction, and it could lead to large bowel obstructions.

A large colonic carcinoma or an inflamed and swollen diverticulum can cause a blockage in the colon, which could lead to constipation.

Finally, problems like anal fissures and hemorrhoids can make defecation so painful that the person will voluntarily avoid passing stool.

The longer the stool stays in the colon, the harder it will become, ultimately making the situation worse.

Medications that are used to manage constipation include: bulk forming agents, stimulant laxatives, osmotic laxatives, and stool softeners.

Let’s start with bulk-forming agents, which include methylcellulose and psyllium.

These fibrous compounds are composed of polysaccharide polymers from plants.

In addition, bulk-forming agents also include synthetic fibers, such as polycarbophil.

Now these medications are taken perorally and can’t be digested by the enzymes in our GI tract.

So these fibers end up getting incorporated into the stool, where they draw in more water, making the stool swell up into a soft, bulky mass, kind of like a stinky sponge.

This increase in size stimulates intestinal motility and the softer stool is also easier to pass.

Bulking agents are great for long-term treatment of constipation but they can also be used to treat acute diarrhea.

Except bloating and flatulence, they don’t have many side effects; but it’s important to note that they should be taken with fluids to avoid fecal impaction.

Finally, they are contraindicated in those with intestinal obstruction as the increased stool mass could worsen the blockage.

Next are the stool softeners, which are also known as emollient laxatives.

The main representative of this group is docusate, which can be taken peroral or per rectum, as a suppository.

Normally water and lipids don’t mix, so the fats in stool could prevent water from entering.

Docusate is a surfactant, which means it has a hydrophilic head that’s water soluble, and a hydrophobic tail that’s water insoluble, so it sticks out into the lipids.

This disrupts the normal surface tension between water and fat, which allows the water to penetrate the stool and make it softer.

Although docusate is widely used, it’s shown to have low efficacy for the treatment of constipation.

However, it can be used to prevent constipation and minimize straining during defecation in hospitalized individuals.

As far as side effects go, docusate can cause diarrhea because it increases intestinal fluid and electrolyte secretion.

Next are the osmotic laxatives, which include saline laxatives, such as magnesium sulfate, magnesium hydroxide, magnesium citrate, and sodium phosphate,; and indigestible alcohols and sugars, like polyethylene glycol, polyethylene glycol-electrolyte solution, and lactulose.

Both magnesium cations and phosphate anions are not well absorbed, so they draw more water out of the cells in the intestinal wall via osmosis and increase the amount of water in the lumen.

This increases intestinal motility, which pushes the stool through the GI tract and also helps mix the stool with water.

Besides treating constipation, magnesium citrate and sodium phosphate can be given rectally to cleanse the bowels before procedures like colonoscopies or surgeries, kind of like using a drain cleaner to clean dirty pipes.

The downside of these medications is that they can cause diarrhea and fluid loss; therefore, individuals treated with saline laxatives should increase fluid intake to prevent dehydration.

In addition, magnesium- and phosphate- containing medications should be avoided in small children and individuals with renal impairment, cardiac conditions, or pre-existing electrolyte disbalance since these individuals are associated with an increased risk of hypermagnesemia and hyperphosphatemia.

Moreover, hypermagnesemia complications include heart block, neuromuscular block, and central nervous system depression; while hyperphosphatemia can lead to acute renal failure due to tubular deposition of calcium phosphate; but also metabolic acidosis, hypocalcemia, tetany, and even death.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Physiology" Elsevier (2017)
  5. "How Useful Is Docusate in Patients at Risk for Constipation? A Systematic Review of the Evidence in the Chronically Ill" Journal of Pain and Symptom Management (2000)
  6. "Systematic Review of Stimulant and Nonstimulant Laxatives for the Treatment of Functional constipation" Canadian Journal of Gastroenterology and Hepatology (2014)